The trading price of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) floating higher at last check on current market day and closing at $0.64, 16.36% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.6036 and $0.6622. In examining the 52-week price action we see that the stock hit a 52-week high of $6.18 and a 52-week low of $0.43. Over the past month, the stock has gained 6.83% in value.
Quoin Pharmaceuticals Ltd ADR, whose market valuation is $3.23 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.43 per share this quarter, however they have predicted annual earnings per share of -2.05 for current year and -1.65 for next year.
On the technical side, indicators suggest QNRX has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned QNRX a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Quoin Pharmaceuticals Ltd ADR (QNRX) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that QNRX’s price is currently -3.46% off the SMA20 and -6.77% off the SMA50. The RSI metric on the 14-day chart is currently showing 50.61, and weekly volatility stands at 20.53%. When measured over the past 30 days, the indicator reaches 21.69%. Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s beta value is currently sitting at 1.80, while the Average True Range indicator is currently displaying 0.11.
To see how Quoin Pharmaceuticals Ltd ADR stock has been performing today in comparison to its peers in the industry, here are the numbers: QNRX stock’s performance was 16.36% at last check in today’s session, and -87.57% in the past year.
An evaluation of the daily trading volume of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) indicates that the 3-month average is 3.30 million. However, this figure has increased over the past 10 days to an average of 2.12.
Currently, records show that 5.05 million of the company’s shares remain outstanding. The institutions hold 3.27%. The stats also highlight that short interest as of 2024-10-15, stood at 19172.0 shares, resulting in a short ratio of 0.2 at that time. From this, we can conclude that short interest is 48.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were down slightly from the previous month’s figure, which was 0.19 million. However, since the stock’s price has seen -86.95% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
